Poor people are less likely to take part in clinical trials for new cancer drugs, which can make it harder to develop treatments, according to a new study.
“Cancer clinical trials are how we move the field forward. As a result of patients not participating in clinical trials, it takes a lot longer and it’s much more expensive to develop new therapies,” said Dr. Dawn Hershman, who worked on the study.






